ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes

Objective. Opioid abuse is a serious public health concern. In response, the Food and Drug Administration (FDA) determined that a risk evaluation and mitigation strategy (REMS) for extended-release and long-acting (ER/LA) opioids was necessary to ensure that the benefits of these analgesics continue...

Descripción completa

Detalles Bibliográficos
Autores principales: Cepeda, M. Soledad, Coplan, Paul M., Kopper, Nathan W., Maziere, Jean-Yves, Wedin, Gregory P., Wallace, Laura E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283702/
https://www.ncbi.nlm.nih.gov/pubmed/27373304
http://dx.doi.org/10.1093/pm/pnw129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283702/
https://www.ncbi.nlm.nih.gov/pubmed/27373304
http://dx.doi.org/10.1093/pm/pnw129

Ejemplares similares